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Abstract. The aim of this research is to know the effect of short-term bitter melon 
(Momordica Charantia L.) fruit concentrated infusions therapy on the histology of 
alloxan-induced rat kidney glomerulus. Renal glomerular histology was observed using 
Hematoxylin-Eosin (HE) test. A therapeutic dose of bitter melon fruit concentrated 
therapy used was 0.15 mL/200 g BW; 0.30 mL/200 g BW; 0.45 mL/200 g BW; 0.60 
mL/200 g BW; 0.80 mL/200 g BW and 1 mL/200 g BW. The results showed that the 
bitter melon fruit concentrated infusions therapy on alloxan-induced DM rats was able to 
decrease the Blood Glucose Levels (BGL) of the treated rats in varying degrees. The 
therapy also successfully repairs the damage kidney glomerulus cells of all rats treated 
with an average bowman's space improvement of 110% of healthy rat's kidney 
glomerulus cells. It appears that the mechanism of the bitter melon active substance in 
reducing the BGL occurs through a different path to its mechanism in repairing damaged 
glomerulus cells. 
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1  Introduction 
Diabetes Mellitus (DM) is a chronic disease characterized by high blood glucose levels 
(BGL) condition (hyperglycemia) due to improperly regulating glucose homeostasis. Chronic 
hyperglycemia leads to over-production of excessive free radicals, which can lead to the 
generation of oxidative stress. Free radicals can damage the cell membrane, if it continues it 
will lead to damage the cell membrane system and cell death [1]. 
Kidneys are the second organs susceptible to the effects of chemicals since these organs 
receive 25-30% of the blood circulation to be cleaned. So that as filtration organs the 
likelihood of pathological changes is very high [2]. DM disease can trigger the occurrence of 
diabetic nephropathy [3], namely complications that occur in fine blood vessels. Damage to 
the blood vessels leads to glomerular damage that serves as a blood filter in the kidneys. High 
levels of glucose in the blood will make the kidneys structure change [4]. Some short-term and 
long-term therapy has been investigated to treat this nephropathy and successfully for both 
term [5]–[8]. 
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Bitter melon (Momordica charantia L.) fruit water extract contains some classes of 
carbohydrate compounds, proteins, amino acids, sterols, flavonoids, phlobatannins, terpenoids, 
glycosides, and saponins [9]. Momordica charantia contains some specific compounds such as 
albuminoid, charantin, hydroxytryptamine, dyes, vitamins A, B, and C [10]. Some of these 
compounds have an antioxidant role that can against free radicals. 
In this study, the method used to extract bitter melon fruit is an infusion. Infusion is one 
of the extraction methods using a solvent such as water, oil or alcohol, by allowing the 
material to remain suspended in the solvent over time at a temperature of 90 ° C without 
evaporation. This method is very effective to apply to the community because it can only use 
water as a solvent while still able to maintain its active ingredients. 
This study will investigate the ability of bitter melon fruit infusions to repair the 
glomerular damage of diabetes mellitus suffering rat (DM rat). Rat induced hyperglycemia 
treated by the alloxan diabetogenic agent. This study aims to determine the effect of 
concentrated infusions therapy of bitter melon fruit on histologic features of renal glomerulus 
of DM rat. 
2  Materials and Methods 
2.1  Material 
The material used is the local bitter melon fruit readily harvested, male Wistar strain 
white rat (Rattus norvegicus) 2-3 months weighing ± 200 g, Alloxan (Alloxan Monohydrate), 
0.9% NaCl, 10% Neutral Buffer Formalin solution, plastics, 70%, 80%, 90% alcohol, absolute 
alcohol, paraffin, and xylol. 
2.2  Preparation of Bitter Melon Fruit Concentrated Infusions 
The method of making infusions follows the standard of the Directorate General of POM 
RI [11], but the simplicia powder is increased to 30 g from the Pharmacopoeia standard of 10 
g, to produce concentrated infusions. Concentrated infusions therapy is given daily for 14 days 
as a fresh solution. The dried bitter melon simplicial powder of 30 g was dissolved in 160 mL 
of water and then put in an infusion pot. The infusion pot is heated in a water bath for 15 
minutes since the temperature reaches 90ºC while stirring occasionally. Filtering is done using 
a white cotton cloth in a still hot solution. The infusions are made fresh every day when it will 
be given as therapy. 
2.3  Experimental Animal Preparation 
The experimental animals to be adapted for ± 3 weeks to a uniform pattern of animal life. 
Feeding and drinking are done daily in ad libitum. The trial was divided into 8 treatment 
groups with 4 mice for each treatment group: 
 
KN: Normal control group without treatment 
KP: Positive DM control group 
KT1: DM group treated with infusions dose 0.15 mL / 200 g BW. 
KT2: DM group treated with infusions dose 0.30 mL / 200 g BW. 
KT3: DM group treated with infusions dose 0.45 mL / 200 g BW. 
KT4: DM group treated with infusions dose 0.60 mL / 200 g BW. 
KT5: DM group treated with infusions dose 0.80 mL / 200 g BW. 
KT6: DM group treated with infusions dose 1 mL / 200 g BW. 
2.4  Diabetes Mellitus Rat Preparation 
Diabetes Mellitus rat prepared by injecting alloxan in its intraperitoneal region on fasted 
condition. Alloxan solution prepared by homogeneously dilute of 896 mg alloxan p.a. in 0.9 % 
NaCl solution until the solution volume was 28 mL. The alloxan solution dose used was 32 
mg/200 g BW [12], [13]. Blood Glucose Levels (BGL) measurements were performed using a 
DR Glucometer through rat tail ends little cutting. The rat will be determined as positive for 
DM if BGL is above 200 mg/dL. 
2.5  Kidney Organ Harvesting 
The rats were dissected after putting to death by neck dislocation. The kidneys are 
removed and rinsed in water, then immersed in 10% Formalin Neutral Buffer solution in a 
sealed container for further analysis. 
2.6  Preparation of Kidney Organs 
The kidney organs were graded dehydrated using an alcohol of concentrations of 70%, 
80%, 90%, absolute alcohols I, II every 2 hours respectively. Then cleared off by xylol and 
molded using paraffin so they were cast in paraffin blocks and then stored in a refrigerator. 
The paraffin blocks are then sliced as thick as 5-6 μm using a microtome. The slice results 
were floated in warm water at 60 ° C to stretch for the tissue not to fold. The preparations 
were then lifted and placed in an object glass for Hematoxylin and Eosin (HE) staining [14], 
[15]. 
2.7  Hematoxylin-Eosin (HE) Stain for Renal Histologic Test 
Preparation was observed under an electron microscope with a magnification of 40x. The 
observed part is the Bowman’s space of glomerulus. Bowman’s space improvement is 
calculated using the percentage formula: 
BS Percent of improvement = ((b)) / ((a)) x 100%      (1) 
where 
Average KT = (Average KT1 to KT6) / 6 
(a) = (Average KP) - (Average KN)  
(b) = (Average KP) - (Average KT)  
3  Result and Discussions 
This study uses an in vivo test. The rats are conditioned for hyperglycemic by alloxan 
induction. Alloxan is a substance that works to increase blood glucose levels so that the rats 
suffer from Diabetes Mellitus (DM). The alloxan induction was done 2 times because in the 
first induction there were still some rats that its BGL have not reached 200 mg/dL so it has not 
determined as DM-positive. BGL measurements were performed on day-0 i.e. before alloxan 
induced and the day after alloxan induction. Day-1 is the day when all the rats have been 
tested as positive for DM. When all the rats were positive DM then given bitter melon fruit 
concentrated infusions therapy for 14 days. On the 15th day, the rats were dissected and the 
kidney organ was taken to be observed. 
     
 
Figure 1. Rat blood glucose levels before treatment (H0), after injection of alloxan (H1), and after 
therapy (H15). 
 
Before any treatment, all rats were in the same condition it had healthy rat's blood glucose 
levels below 200 mg/dL. The BGL condition of all rats after alloxan induction was DM-
positive with a BGL value of above 400 mg/dL. After bitter melon fruit concentrated infusions 
therapy for 14 days were given, the rat's BGLs decreased substantially. The greatest decrease 
in BGL occurred in rat with bitter melon fruit concentrated infusions therapy at a dose of 0.3 
mL. While the DM-positive rats without therapy, until day-15 have a steadily increasing BGL 
until reach an average value of 450 mg/dL. 
Figure 2 shows that the glomerulus of DM rat (KP) has been damaged. The glomerulus 
undergoes considerable damage and decreases in the number of cells, resulting in a 
broadening of the Bowman's space to reach 5866.232 μm2 (see Table 1). The Glomerular cell 
damage rate in diabetic rats was twice that of healthy rat (KN). The presence of samples with 
mild or moderate necrosis in the normal control (KN) and treatment control (KT) group in 
Figure 1 was normal due to the aging process and cell death that physiologically occurs in all 
normal cells. Every cell in a body will always experience aging, which ends with cell death 
and is replaced by new cells through the regeneration process [16], [17]. In addition, the 
influence of psychological condition affected by the surrounding environment and different 
hypersensitivity reactions in each rat can also affect the aging process. 
 
 
      
 
     
      
 
     
 
Figure 2. Rat’s kidney glomerulus cells histology of each treatment. (a) KN, (b) KP, (c) KT1, (d) KT2, 
(e) KT3, (f) KT4, (g) KT5, (h) KT6. 
 
 
Table 1 shows that there is a difference between health rat (KN), diabetic rat (KP), and 
treated rats (KT) Bowman’s space. The average of Bowman’s space in health rat was 
2947,215 μm2. KP shows the average of the Bowman’s space has widened to 5866.232 μm2. 
KT1, KT2, KT3, KT4, KT5, and KT6 have a wide narrowing of the Bowman’s space back. 
The narrowing Bowman’s space indicates a repairing health glomerulus cells. The six 
therapeutic doses did not show significant differences in glomerular cell repairing degree. The 
average ability of bitter melon fruit concentrated infusions therapy in improving the rat 
Bowman's space was 110% of the health one. The BGL data after the rats were treated by 
bitter melon fruit concentrated infusions shows a tendency that it is not in line with the 
improvement degree of glomerular cells. The improvement of glomerular cells in treating rats 
occurs to almost perfectly with an average value of 110% at all therapeutic doses. Glomerular 
cell returns to a healthy state with a value of the Bowman's space approaching the mean value 
of a healthy one. While the value of rat BGLs after therapy in different doses showed varying 
degrees of decreasing values. This indicates that the repairing mechanism of glomerular cells 
occurs through a different path to the mechanism of decreasing blood glucose levels. 
 
Table 1. Bowman’s Space Average Of All Rat Kidneys 
 
Group Bowman’s Space 
(µm2) 
KN (health) 2947.215 
KP (DM-
positive) 
5866.232 
KT1 2642.015 
KT2 2368.635 
KT3 2540.445 
KT4 2269.607 
KT5 3470.090 
KT6 2527.930 
              
 
Chronic hyperglycemia conditions encourage free radical production excessively. The 
formation of excess free radicals in diabetes triggers a decrease in antioxidant content and 
tissue damage. Antioxidants serve as the body's defense against free radicals that induce 
oxidative stress and reactive oxygen compounds in plasma and cells so that cell damage does 
not occur. Some active ingredients in concentrated infusions of bitter melon fruit are 
antioxidants, namely vitamin C (ascorbic acid) and flavonoids. Vitamin C (L-Ascorbic Acid) 
is a natural compound that is a powerful antioxidant and free radical binder but not enzymatic 
[18], [19]. Vitamin C will work extracellularly, which is to reduce the superoxide radical 
produced in the process of glucose autoxidation and nitric oxide synthesis. When superoxide 
radicals are excessive, there will be a reaction with nitric oxide producing a cytotoxic 
peroxynitrite radical. Inhibition of the formation of peroxynitrite radicals will maintain the 
vasodilation function of blood vessels played by nitric oxide. In endothelial cells, ascorbic 
acid affects the nitric oxide synthase enzyme so that superoxide radicals as byproducts of 
nitric oxide formation can be suppressed and antioxidants and free radicals will be balanced 
[21]. Due to the balance of antioxidants and free radicals will effect on repair glomerulus. 
Bitter melon fruit infusions also contain flavonoids. Polyphenol compounds, especially 
flavonoids, are thought to play a role in the inhibition of lipid peroxidation because they have 
the ability to capture free radicals as a free radical scavenger. Flavonoids donate an H atom of 
hydroxyl phenolic groups when reacting with free radicals. As an antioxidant, flavonoid 
compounds will react with free radicals resulting in stable products and reduced cellular 
damage [22]. 
4  Conclusion 
The concentrated infusions therapy of bitter melon fruit on alloxan-induced DM rats was 
able to decrease the Blood Glucose Levels (BGL) of the treated rats in varying degrees. The 
therapy also successfully repairs the damage kidney glomerulus cells almost perfectly. It 
appears that the mechanism of the bitter melon active substance in reducing the BGL occurs 
through a different path to its mechanism in repairing damaged glomerulus cells. 
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